BJCT-BIOJECT-needle less injection product Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BJCT-BIOJECT-needle less injection product

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: GREG FINLEY who wrote (270)	7/22/1998 9:40:00 PM
From: Marc Kahn	Read Replies (1) of 534

From the press release, here's a quote from the president of GeneMedicine: "As the only FDA-approved needle-free delivery device for intramuscular injections coupled with its potential to enhance immunological response, Bioject's system is ideally suited to improve the effectiveness of our own technologies in the delivery of genetic vaccines." Folks, there are dozens of companies developing DNA based vaccines. It looks to me that every one of them will NEED our proprietary technology. This is a very exciting time to be a Bioject shareholder! Marc Kahn

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next